v3.26.1
Condensed Financial Information of the Parent Company
12 Months Ended
Dec. 31, 2025
Condensed Financial Information Disclosure [Abstract]  
CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY
25.
CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY

Condensed Balance Sheets

 

 

As of December 31,

 

 

 

Note

 

 

2024

 

 

2025

 

 

2025

 

 

 

 

 

 

RMB

 

 

RMB

 

 

US$

 

 

 

 

 

 

(In thousands)

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

887,386

 

 

 

1,615,986

 

 

 

231,083

 

Prepayments and other assets

 

 

 

 

 

2,543

 

 

 

19,043

 

 

 

2,723

 

Amounts due from entities within the Group

 

 

 

 

 

21,082,425

 

 

 

19,898,404

 

 

 

2,845,435

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total current assets

 

 

 

 

 

21,972,354

 

 

 

21,533,433

 

 

 

3,079,241

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total non-current assets

 

 

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

 

 

 

 

21,972,354

 

 

 

21,533,433

 

 

 

3,079,241

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Convertible senior notes

 

 

14

 

 

 

242,460

 

 

 

1,459,151

 

 

 

208,656

 

Accrued expenses and other liabilities

 

 

 

 

 

13,898

 

 

 

45,808

 

 

 

6,550

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total current liabilities

 

 

 

 

 

256,358

 

 

 

1,504,959

 

 

 

215,206

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Convertible senior notes

 

 

14

 

 

 

8,350,570

 

 

 

6,711,948

 

 

 

959,796

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total non-current liabilities

 

 

 

 

 

8,350,570

 

 

 

6,711,948

 

 

 

959,796

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total liabilities

 

 

 

 

 

8,606,928

 

 

 

8,216,907

 

 

 

1,175,002

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

17

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

Class A ordinary shares (US$0.00001 par value;
      
94,000,000,000 shares authorized as of December 31,
      2024 and 2025, respectively;
3,854,584,680 and
      
3,855,283,602 shares issued as of December 31,
      2024 and 2025, respectively;
3,698,793,887 and
      
3,713,284,286 shares outstanding as of December 31,
      2024 and 2025, respectively)

 

 

18

 

 

 

238

 

 

 

239

 

 

 

34

 

Class B ordinary shares (US$0.00001 par value;
      
5,000,000,000 shares authorized as of December 31,
      2024 and 2025;
3,041,097,278 shares issued and
      outstanding as of December 31, 2024 and 2025)

 

 

18

 

 

 

193

 

 

 

193

 

 

 

28

 

Additional paid-in capital

 

 

 

 

 

55,623,841

 

 

 

56,026,232

 

 

 

8,011,645

 

Accumulated deficit

 

 

19

 

 

 

(43,809,369

)

 

 

(44,015,680

)

 

 

(6,294,158

)

Accumulated other comprehensive income

 

 

24

 

 

 

1,550,523

 

 

 

1,305,542

 

 

 

186,690

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total shareholders’ equity

 

 

 

 

 

13,365,426

 

 

 

13,316,526

 

 

 

1,904,239

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total liabilities and shareholders’ equity

 

 

 

 

 

21,972,354

 

 

 

21,533,433

 

 

 

3,079,241

 

 

Condensed Statements of Comprehensive Income/(Loss)

 

 

Year ended December 31,

 

 

 

2023

 

 

2024

 

 

2025

 

 

2025

 

 

 

RMB

 

 

RMB

 

 

RMB

 

 

US$

 

 

 

(In thousands)

 

Operating costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

(11,397

)

 

 

(13,814

)

 

 

(14,893

)

 

 

(2,130

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating loss

 

 

 

 

 

 

 

 

 

 

 

 

Share of income/(losses) of subsidiaries, VIEs and VIEs’ subsidiaries

 

 

2,975,000

 

 

 

1,844,679

 

 

 

(751,561

)

 

 

(107,472

)

Interest income

 

 

115,209

 

 

 

59,742

 

 

 

41,912

 

 

 

5,993

 

Interest expenses

 

 

(726,487

)

 

 

(672,647

)

 

 

(334,890

)

 

 

(47,889

)

Foreign exchange gain/(loss), net

 

 

(665,335

)

 

 

(640,334

)

 

 

707,365

 

 

 

101,152

 

Others, net

 

 

238,479

 

 

 

186,433

 

 

 

145,756

 

 

 

20,844

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

1,925,469

 

 

 

764,059

 

 

 

(206,311

)

 

 

(29,502

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to ordinary shareholders

 

 

1,925,469

 

 

 

764,059

 

 

 

(206,311

)

 

 

(29,502

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

(164,040

)

 

 

(134,533

)

 

 

(95,805

)

 

 

(13,700

)

Unrealized losses on available-for-sale
      debt securities

 

 

(11,367

)

 

 

(2,991

)

 

 

(149,176

)

 

 

(21,332

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Total other comprehensive loss, net of tax

 

 

(175,407

)

 

 

(137,524

)

 

 

(244,981

)

 

 

(35,032

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive income/(loss)

 

 

1,750,062

 

 

 

626,535

 

 

 

(451,292

)

 

 

(64,534

)

 

Condensed Statements of Cash Flows

 

 

 

Year ended December 31,

 

 

 

2023

 

 

2024

 

 

2025

 

 

2025

 

 

 

RMB

 

 

RMB

 

 

RMB

 

 

US$

 

 

 

(In thousands)

 

Net cash used for operating activities

 

 

(370,682

)

 

 

(35,985

)

 

 

(69,191

)

 

 

(9,894

)

Net cash provided by investing activities

 

 

238,001

 

 

 

3,384,507

 

 

 

1,185,440

 

 

 

169,516

 

Net cash used for financing activities

 

 

(3,859,442

)

 

 

(2,873,166

)

 

 

(338,134

)

 

 

(48,353

)

Effect of exchange rate changes on cash and cash equivalents

 

 

58,157

 

 

 

11,028

 

 

 

(49,515

)

 

 

(7,081

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

 

 

(3,933,966

)

 

 

486,384

 

 

 

728,600

 

 

 

104,188

 

Cash and cash equivalents at the beginning of the year

 

 

4,334,968

 

 

 

401,002

 

 

 

887,386

 

 

 

126,895

 

Cash and cash equivalents at the end of the year

 

 

401,002

 

 

 

887,386

 

 

 

1,615,986

 

 

 

231,083

 

 

Basis of presentation

For the presentation of the parent company only condensed financial information, the Company records its investments in subsidiaries and VIEs under the equity method of accounting as prescribed in ASC 323. The subsidiaries, VIEs and VIEs’ subsidiaries income or losses are reported as “Share of income/(losses) of subsidiaries, VIEs and VIEs’ subsidiaries” on the condensed statements of comprehensive income/(loss). Under the equity method of accounting, the Company’s carrying amount of its investment in subsidiaries, VIEs and VIEs’ subsidiaries was reduced to nil as of December 31, 2024 and 2025, and the carrying amount of “Amounts due from entities within the Group” was further adjusted as the Company committed to provide financial support to its VIEs as disclosed in Note 1.

The Company does not have significant commitments or long-term obligations as of the period end other than those presented.

The parent company only financial statements should be read in conjunction with the Company’s consolidated financial statements.